Current:Home > ScamsCOVID-19 treatments to enter the market with a hefty price tag-InfoLens
COVID-19 treatments to enter the market with a hefty price tag
View Date:2024-12-23 12:00:38
WASHINGTON (AP) — The COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag.
Pharmaceutical giant Pfizer is setting the price for a five-day treatment of Paxlovid at $1,390, but Americans can still access the pills at no cost -- for now. The less commonly used COVID-19 treatment Lagevrio, manufactured by Merck, also will hit the market next week.
Millions of free, taxpayer-funded courses of the pills will remain at pharmacies, hospitals and doctor’s offices across the country, U.S. Health and Human Services officials said Friday. People on private insurance may start to notice copays for the treatments once their pharmacy or doctor’s office runs out of the COVID-19 treatments they received from the government.
The U.S. government initially inked a deal with Pfizer to pay more than $5 billion for 10 million courses of Paxlovid in 2021.
Under a new agreement, reached last month between Pfizer and the federal government, people on Medicaid, Medicare or those who are without medical insurance will not pay any out-of-pocket costs for the treatment through the end of next year. Pfizer will also offer copay assistance for the treatment through 2028. The Department of Veterans Affairs, the Department of Defense and Indian Health Service will still be able to access Paxlovid the government has on hand. The government will also get 1 million treatment courses to keep in its stockpile.
Suppliers to pharmacies, doctor’s offices and hospitals can begin ordering the treatments from the drug companies starting next week.
“Pfizer is committed to a smooth commercial transition and is working collaboratively with the U.S. government and health care stakeholders to ensure broad and equitable access to this important medicine for all eligible patients,” the company said in an emailed statement to The Associated Press.
Paxlovid has been used to treat COVID-19 since 2021, but the Food and Drug Administration granted full approval earlier this year for it to be used on adults with coronavirus who face high risks of hospitalization or death. That group typically includes older adults and those with medical conditions like diabetes, asthma and obesity.
Full-year revenue for Paxlovid and Pfizer’s COVID-19 vaccine, Comirnaty, is expected to be approximately $12.5 billion.
Merck has not confirmed a list price yet for its Lagevrio treatment but said in a statement to AP that it will also offer the treatment free to patients “who, without assistance, could not otherwise afford the product.”
—
Associated Press reporter Tom Murphy in Indianapolis contributed to this report.
veryGood! (54)
Related
- Are banks, post offices, UPS and FedEx open on Veterans Day? Here's what to know
- 2023 New York Film Festival opens with Natalie Portman-Julianne Moore spellbinder May December
- Spain’s women’s team players Putellas, Rodríguez and Paredes appear before a judge in Rubiales probe
- Apple to fix iPhone 15 bug blamed for phones overheating
- Jason Kelce Offers Up NSFW Explanation for Why Men Have Beards
- Florida officers under investigation after viral traffic stop video showed bloodied Black man
- 2023 New York Film Festival opens with Natalie Portman-Julianne Moore spellbinder May December
- Gavin Newsom picks Laphonza Butler to fill Dianne Feinstein's Senate seat
- Jennifer Lopez Turns Wicked Premiere Into Family Outing With 16-Year-Old Emme
- The military is turning to microgrids to fight global threats — and global warming
Ranking
- Reese Witherspoon's Daughter Ava Phillippe Introduces Adorable New Family Member
- Looks like we picked the wrong week to quit quoting 'Airplane!'
- 5 Things podcast: Does an uptick in strikes (UAW, WGA, etc.) mean unions are strengthening?
- The UAE holds a major oil and gas conference just ahead of hosting UN climate talks in Dubai
- 'Red One' review: Dwayne Johnson, Chris Evans embark on a joyless search for Santa
- New Jersey Sen. Bob Menendez expected back in Manhattan court for bribery case
- Chicago woman, 104, skydives from plane, aiming for record as the world’s oldest skydiver
- Judge plans May trial for US Sen. Bob Menendez in bribery case
Recommendation
-
Lions QB Jared Goff, despite 5 interceptions, dared to become cold-blooded
-
Government sues Union Pacific over using flawed test to disqualify color blind railroad workers
-
Nobel Prize goes to scientists who made mRNA COVID vaccines possible
-
UN Security Council approves sending a Kenya-led force to Haiti to fight violent gangs
-
After Baltimore mass shooting, neighborhood goes full year with no homicides
-
Taco Bell worker hospitalized after angry customer opens fire inside Charlotte restaurant
-
Vuitton transforms Paris with a playful spectacle of color, stars and history
-
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook